This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. An increasing number of pharma professionals are relying on marketintelligence platforms to stay on top of these movements while providing the tools they need to devise a business or investment strategy.
For more than a decade, we’ve been dedicated to the goal of delivering insights to our customers through the use of our proprietary AI technology. And today, we’re proud to say that AlphaSense is the world’s most robust marketintelligence search platform for professionals across all industries. Our solution?
From billion-dollar funding for research on widespread health adversities to manufacturing new technologies to address them, the virus has ramped up lucrative investment opportunities in nearly every industry sector. Since the onset of the COVID-19 pandemic, the pharma industry has experienced rapid, radical change.
Moderna and BioTech, the pharmaceuticals companies behind the Moderna vaccines for the COVID-19 virus, just announced a new treatment this past December that would greatly reduce the chances of death from melanoma — stirring up substantial interest in investors to funnel capital. a potential cure for skin cancer.
Trident Technologies – In March 2019, OceanSound acquired Trident Technologies, a provider of advanced IT, engineering, and programmatic solutions to the federal government based in Huntsville, AL. Department of State (DOS), and commercial clients in the pharmaceutical, financial services and education sectors.
This research often includes assessing the financial performance, market potential, competitive landscape, regulatory environment and growth potential of target healthcare companies, drugs, medical technologies, treatments and more.
What are consumers interested in worldwide – and how are marketers aggregating, analyzing and taking action around these interests? Our Global Consumer Insight Analytics Report shares best practices and challenges from leading consumer and marketingintelligence professionals located around the world.
Data visualizations on the platform not only help you uncover actionable consumer and marketintelligence , but they also aid in sharing your intel to anyone within your organization, so they comprehend the scope of the story the data tells at a glance. Hootsuite is a highly regarded social media account management and monitoring tool.
Over the years, especially post the completion of Human Genome Project in 2003, genome sequencing technology has advanced in terms of both time taken for sequencing a genome and the cost involved in sequencing it. million by 2028 growing at a CAGR of 19.8%.
Our report details this shift across various sectors, including Banking and Finance, Consumer Products, Food and Beverage, Healthcare and Pharmaceutical, Media and Entertainment, Retail, Technology, Transportation, and Travel and Hospitality. On the contrary, it indicates that many brands bring their consumer insight efforts in-house.
The recent development in technologies which includes molecular biomarker analysis, companion diagnostics, and gene therapies are aiding therapeutics to adopt and promote precision medicine. This growth of the market is aided by the impressive growth in the digital health and information technologymarket.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial marketintelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.
The financial burden of manufacturing biological medicines involves using cutting-edge technologies to extract large complex molecules derived from living cells–a challenging and expensive process. Expect maybe new evaluations, new technologies rapidly coming. being a more flexible market for biosimilars than the U.S.
Expert networks are a critical tool for marketintelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. Calculate the return on investment (ROI) of your marketintelligence by using our ROI calculator.
President Biden’s Inflation Reduction Act (IRA) is making history within the pharmaceutical space: for the first time, Medicare will negotiate the prices of prescription drugs. The IRA’s impact on drug negotiations and financial exposure could also change the balance of technologies and disease states that are funded in the future.
Regardless of this divergence in opinion, weight loss drugs like Ozempic, Wegovy, and Mounjaro offer a promising opportunity in the healthcare and pharmaceuticalmarket, with innovation and research continually striving to provide safer and more effective solutions for those in need. And the market is just huge.” Stahl says.
Businesses are embracing a technology-driven approach to gain a competitive advantage. The right to challenge assumptions (A) An internal market analyst should be expected to challenge internal assumptions that are not robust. The analyst should be drawing on a variety of both primary and secondary intelligence.
Growing both our customer base and employee presence in Singapore will strengthen this effort even further, especially in such a crucial economy like the Asia-Pacific region, and help us adapt to new circumstances and market shifts more effectively. To support these efforts, we are doubling down on talent recruitment in Singapore.
Although, the vaccine market is small as compared to the pharmaceuticalmarket in the healthcare industry but has showcased a better growth rate than the pharmaceuticalmarket. billion in 2017 and is expected to reach $103.57 billion by 2028, growing at a CAGR of 11% during the forecast period (2018 – 2028).
In fact, most marketintelligence platforms lack access to this form of intel, not only leaving blind spots in your research, but also a window for you to overlook lucrative market opportunities. What are the latest profitability and market size figures for pharmaceutical drug distribution?
And to accomplish this, more and more businesses are embracing digital transformation by adopting intelligent spending and business network technologies. timber, natural pharmaceuticals) and services (i.e., In fact, biodiversity attrition can also severely hinder a company’s bottom line. AlphaSense is that and more.
In addition to this, several automated and semi-automated systems have been developed based on technologies such as real-time polymerase chain reaction (PCR), flow cytometry, matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometer, and bioluminescence technology.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
The introduction of technologies such as artificial intelligence and machine learning have transformed several sectors, including the robotics and UAV industry. With the increasing applicability of mobile robots across various sectors, the mobile robot market is emerging to be one of the most competitive markets.
Technological advancements in the healthcare industry and the field of life sciences along with better understanding of cellular functions and metabolism have led to the development of immunotherapy approach for cancer. According to the World Health Organization (WHO), cancer was responsible for approximate of 8.8 million and 9.6
AlphaSense, a leading AI-based marketintelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. Performing comprehensive due diligence means keeping your finger on the pulse of your entire target company, market landscape, and competitors at all times —and fast.
Pharmaceutical and medical device companies may consult with a KOL when it comes to development and testing. And that’s because they can provide unique insights, such as product improvement or even market messaging. He is well respected, and his opinion is valued. Daniel Kraft, MD (@daniel_kraft) June 16, 2022.
Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.
This guide will compare 12 of the top competitor analysis tools on the market today, highlighting factors you need to know about to choose the right one: key features, limitations, capabilities, cost, and more. It enables a granular understanding of competitive landscapes, customer shifts, and sector-specific trends.
In order to have complete competitive intelligence, you must be able to source data from the thousands of places it exists online. It’s impossible to do this without the right technology to support the process. Enter: competitive intelligence tools.
This past September, Danish pharmaceutical company Novo Nordisk surpassed LVMH to become the most valuable listed company in Europe due to a surge in demand for its highly efficient diabetes and weight-loss medications, Ozempic and Wegovy. AlphaSense provides this and more.
AlphaSense, a leading artificial intelligence (AI)-based marketintelligence platform , offers proprietary Expert Insights through its extensive expert transcript library and Expert Call Services. Those insights aren’t just interesting—they’re investable. If you’re going to force me into TPU, that’s like locking me in.
Since the inception of the COVID-19 pandemic , artificial intelligence (AI) has ushered in a transformative era in drug discovery , development, and healthcare. According to Precedence Research , the AI market within the healthcare sector is projected to surpass $20.6 billion in 2023.
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.
The Value: AlphaSense is an AI-powered search engine for marketintelligence. And with Stream in AlphaSense, users can leverage expert perspectives against insights derived from our extensive and ever-growing universe of content, gaining a 360 view on any market, industry, or trend.
Instead, they are turning to a more centralized approach to research and are using artificial intelligence (AI) to help them filter through the noise, inform more confident decision-making, and share marketintelligence with their broader organizations.
News and Trade Journals News and trade journals are primarily used by companies to understand how the press is speaking about competitors, which provides insight into competitors market positioning, how they are perceived by the public, and what they are most known for. Start your free trial today.
News and Trade Journals News and trade journals are primarily used by companies to understand how the press is speaking about competitors, which provides insight into competitors market positioning, how they are perceived by the public, and what they are most known for. Start your free trial today.
But you must, absolutely must, try it or forever be thought of as a glorified archivist Change driver 1: Technology. Most of you recognize the effect technological change can have on your company. However, in the Big Picture, adoption of technology, or failure to adopt, is not limited to individual companies in a few industries.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content